Insights into the molecular basis of ligand binding by the cholecystokinin receptor

被引:1
作者
Miller, LJ [1 ]
Ding, XQ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA
关键词
cholecystokinin; G-protein-coupled receptors; photoaffinity labeling; mutagenesis;
D O I
10.1159/000055832
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The receptor for the peptide hormone, cholecystokinin, is a G-protein-coupled receptor in the rhodopsin/beta -adrenergic receptor family. A number of methodological approaches have been utilized to gain insights into the molecular basis for natural peptide ligand binding and activation of this physiologically important receptor. Insights into this have come from sequence analysis, ligand and receptor structure-activity data, receptor mutagenesis, conformational analysis of ligand and receptor fragments, and photoaffinity labeling. In this work, we review the contributions of each of these complementary approaches and provide a current integrated view of the active complex of cholecystokinin bound to its receptor. Copyright (C) 2001 S. Karger AG, Basel and IAP.
引用
收藏
页码:336 / 342
页数:7
相关论文
共 50 条
[41]   Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients [J].
Zhu, Jian ;
Han, Tian-Quan ;
Chen, Sheng ;
Jiang, Yu ;
Zhang, Sheng-Dao .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (11) :1685-1689
[42]   In Silico Characterization of Ligand Binding Modes in the Human Histamine H4 Receptor and their Impact on Receptor Activation [J].
Werner, Tim ;
Sander, Kerstin ;
Tanrikulu, Yusuf ;
Kottke, Tim ;
Proschak, Ewgenij ;
Stark, Holger ;
Schneider, Gisbert .
CHEMBIOCHEM, 2010, 11 (13) :1850-1855
[43]   Cholecystokinin A receptor gene promoter polymorphism and intelligence [J].
Shimokata, H ;
Ando, F ;
Niino, N ;
Miyasaka, K ;
Funakoshi, A .
ANNALS OF EPIDEMIOLOGY, 2005, 15 (03) :196-201
[44]   Therapeutic and chemical developments of cholecystokinin receptor ligands [J].
de Tullio, P ;
Delarge, J ;
Pirotte, B .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) :129-146
[45]   CHOLECYSTOKININ RECEPTOR CHARACTERIZATION AND CHOLECYSTOKININ-A RECEPTOR MESSENGER-RNA EXPRESSION IN TRANSGENIC MOUSE PANCREATIC CARCINOMAS AND DYSPLASTIC PANCREAS [J].
POVOSKI, SP ;
ZHOU, WG ;
LONGNECKER, DS ;
BELL, RH .
ONCOLOGY RESEARCH, 1994, 6 (09) :411-417
[46]   New insights into the molecular mechanisms of A1 adenosine receptor action [J].
Rivkees, SA ;
IJzerman, AP ;
Swanson, T .
DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) :93-102
[47]   CHARACTERIZATION OF CLONED HUMAN CHOLECYSTOKININ-B RECEPTOR AS A GASTRIN RECEPTOR [J].
MIYAKE, A ;
MOCHIZUKI, S ;
KAWASHIMA, H .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (08) :1339-1343
[48]   Molecular Basis for the Selectivity of the Mammalian Bombesin Peptide, Neuromedin B, for Its Receptor [J].
Gonzalez, Nieves ;
Nakagawa, Tomoo ;
Mantey, Samuel A. ;
Sancho, Veronica ;
Uehara, Hirotsugu ;
Katsuno, Tatsuro ;
Jensen, Robert T. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (01) :265-276
[49]   Binding chemistry and molecular heterogeneity of neurotensin binding protein(s)/receptor in adult chicken tissues [J].
Mitra, Sankar P. .
INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2013, 50 (06) :511-520
[50]   Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists [J].
Niederau, C ;
Grendell, JH .
DIGESTION, 1999, 60 :69-74